September 15-18, 2025
Hynes Convention CenterBoston, USAKey Sessions
Susan Sharfstein, PhD
KEYNOTE: Clonal variation and modulation of glycosylation in development of a biosimilar
University at Albany
Thomas Seewoester
PLENARY KEYNOTE: Readiness of Biomanufacturing for the Digital Highway
Amgen
Tracy Ryan
PLENARY KEYNOTE: From Immune Anarchy to Precision Healing: Sophie’s Journey and the Rise of NKore
NKore BioTherapeutics
Kartik Subramanian, Ph.D.
PLENARY KEYNOTE: The Future of Biologics Manufacturing: Automation, Digitalization, and Innovation
AbbVie
Wolfram Carius, PhD
Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Bayer Pharmaceuticals